MBD2 and neoplasm: The oncogenic or tumor-suppressive feature of demethylases may not be determined by overall m6A levels, but rather by m6A dynamics on specific key target genes driving leukemogenesis, such as ELK3, which is evidently not a shared target with ALKBH5.